MR. McCLELLAN: I saw that report. A couple of things. First of all, that decision is a matter for the FDA. And in terms of the advisory panel that you're referring to, those are appointments made by the Secretary of Health and Human Services. The Secretary is one who appoints people to that advisory panel. And in terms of the reports, I did an initial look into it, and I know no one in personnel, from my understanding, had talked to him about it. And I'll continue to look into it, see if there's any additional information.